TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Non-Invasive Cancer Diagnostics Market Report & Forecast 2022-2028

Global and United States Non-Invasive Cancer Diagnostics Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 14 September 2022
  • Pages :95
  • Formats:
  • Report Code:SMR-7352459
OfferClick for best price

Best Price: $3480

NonInvasive Cancer Diagnostics Market Size, Share 2022


Market Analysis and Insights: Global NonInvasive Cancer Diagnostics Market

The global NonInvasive Cancer Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NonInvasive Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NonInvasive Cancer Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NonInvasive Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NonInvasive Cancer Diagnostics market.

Global NonInvasive Cancer Diagnostics Scope and Market Size

Non-Invasive Cancer Diagnostics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Non-Invasive Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Non-Invasive Cancer Diagnostics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

CTCs

CTNAS

Exosomes

Segment by Application

Blood

Urine

Saliva

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Gen-Probe Inc

Digene Corporation

Quest Diagnostics Inc

Cancer, Genetics Inc

BIOVIEW Inc

AVIVA Biosciences Corporation

Laboratory Corporation of America Holdings (LabCorp)

A&G Pharmaceutical

Affymetrix Inc

Precision Therapeutics

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes NonInvasive Cancer Diagnostics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of NonInvasive Cancer Diagnostics, with price, sales, revenue, and global market share of NonInvasive Cancer Diagnostics from 2019 to 2022.

Chapter 3, the NonInvasive Cancer Diagnostics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the NonInvasive Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the NonInvasive Cancer Diagnostics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of NonInvasive Cancer Diagnostics.

Chapter 13, 14, and 15, to describe NonInvasive Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 NonInvasive Cancer Diagnostics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Non-Invasive Cancer Diagnostics Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 95 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Non-Invasive Cancer Diagnostics Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Non-Invasive Cancer Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Non-Invasive Cancer Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Non-Invasive Cancer Diagnostics Market Size for the Year 2017-2028
1.3 Non-Invasive Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Non-Invasive Cancer Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Non-Invasive Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Non-Invasive Cancer Diagnostics Market Dynamics
1.4.1 Non-Invasive Cancer Diagnostics Industry Trends
1.4.2 Non-Invasive Cancer Diagnostics Market Drivers
1.4.3 Non-Invasive Cancer Diagnostics Market Challenges
1.4.4 Non-Invasive Cancer Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Non-Invasive Cancer Diagnostics by Type
2.1 Non-Invasive Cancer Diagnostics Market Segment by Type
2.1.1 CTCs
2.1.2 CTNAS
2.1.3 Exosomes
2.2 Global Non-Invasive Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Non-Invasive Cancer Diagnostics Market Size by Type (2017-2028)
2.4 United States Non-Invasive Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Non-Invasive Cancer Diagnostics Market Size by Type (2017-2028)
3 Non-Invasive Cancer Diagnostics by Application
3.1 Non-Invasive Cancer Diagnostics Market Segment by Application
3.1.1 Blood
3.1.2 Urine
3.1.3 Saliva
3.2 Global Non-Invasive Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Non-Invasive Cancer Diagnostics Market Size by Application (2017-2028)
3.4 United States Non-Invasive Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Non-Invasive Cancer Diagnostics Market Size by Application (2017-2028)
4 Global Non-Invasive Cancer Diagnostics Competitor Landscape by Company
4.1 Global Non-Invasive Cancer Diagnostics Market Size by Company
4.1.1 Top Global Non-Invasive Cancer Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Non-Invasive Cancer Diagnostics Revenue by Player (2017-2022)
4.2 Global Non-Invasive Cancer Diagnostics Concentration Ratio (CR)
4.2.1 Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Non-Invasive Cancer Diagnostics in 2021
4.2.3 Global Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Non-Invasive Cancer Diagnostics Headquarters, Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Non-Invasive Cancer Diagnostics Headquarters and Area Served
4.3.2 Global Non-Invasive Cancer Diagnostics Companies Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Non-Invasive Cancer Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Non-Invasive Cancer Diagnostics Market Size by Company
4.5.1 Top Non-Invasive Cancer Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Non-Invasive Cancer Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Non-Invasive Cancer Diagnostics Market Size by Region
5.1 Global Non-Invasive Cancer Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Non-Invasive Cancer Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Non-Invasive Cancer Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Non-Invasive Cancer Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Non-Invasive Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Non-Invasive Cancer Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Non-Invasive Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Non-Invasive Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Non-Invasive Cancer Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Non-Invasive Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Gen-Probe Inc
7.1.1 Gen-Probe Inc Company Details
7.1.2 Gen-Probe Inc Business Overview
7.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Introduction
7.1.4 Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.1.5 Gen-Probe Inc Recent Development
7.2 Digene Corporation
7.2.1 Digene Corporation Company Details
7.2.2 Digene Corporation Business Overview
7.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Introduction
7.2.4 Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.2.5 Digene Corporation Recent Development
7.3 Quest Diagnostics Inc
7.3.1 Quest Diagnostics Inc Company Details
7.3.2 Quest Diagnostics Inc Business Overview
7.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Introduction
7.3.4 Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.3.5 Quest Diagnostics Inc Recent Development
7.4 Cancer, Genetics Inc
7.4.1 Cancer, Genetics Inc Company Details
7.4.2 Cancer, Genetics Inc Business Overview
7.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Introduction
7.4.4 Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.4.5 Cancer, Genetics Inc Recent Development
7.5 BIOVIEW Inc
7.5.1 BIOVIEW Inc Company Details
7.5.2 BIOVIEW Inc Business Overview
7.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Introduction
7.5.4 BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.5.5 BIOVIEW Inc Recent Development
7.6 AVIVA Biosciences Corporation
7.6.1 AVIVA Biosciences Corporation Company Details
7.6.2 AVIVA Biosciences Corporation Business Overview
7.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Introduction
7.6.4 AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.6.5 AVIVA Biosciences Corporation Recent Development
7.7 Laboratory Corporation of America Holdings (LabCorp)
7.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
7.7.2 Laboratory Corporation of America Holdings (LabCorp) Business Overview
7.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Introduction
7.7.4 Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
7.8 A&G Pharmaceutical
7.8.1 A&G Pharmaceutical Company Details
7.8.2 A&G Pharmaceutical Business Overview
7.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Introduction
7.8.4 A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.8.5 A&G Pharmaceutical Recent Development
7.9 Affymetrix Inc
7.9.1 Affymetrix Inc Company Details
7.9.2 Affymetrix Inc Business Overview
7.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Introduction
7.9.4 Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.9.5 Affymetrix Inc Recent Development
7.10 Precision Therapeutics
7.10.1 Precision Therapeutics Company Details
7.10.2 Precision Therapeutics Business Overview
7.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Introduction
7.10.4 Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022)
7.10.5 Precision Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Non-Invasive Cancer Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Non-Invasive Cancer Diagnostics Market Trends
Table 3. Non-Invasive Cancer Diagnostics Market Drivers
Table 4. Non-Invasive Cancer Diagnostics Market Challenges
Table 5. Non-Invasive Cancer Diagnostics Market Restraints
Table 6. Global Non-Invasive Cancer Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Non-Invasive Cancer Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Non-Invasive Cancer Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Non-Invasive Cancer Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Non-Invasive Cancer Diagnostics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Non-Invasive Cancer Diagnostics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Non-Invasive Cancer Diagnostics Revenue Share by Player, 2017-2022
Table 13. Global Non-Invasive Cancer Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-Invasive Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Cancer Diagnostics as of 2021)
Table 15. Top Players of Non-Invasive Cancer Diagnostics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Non-Invasive Cancer Diagnostics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Non-Invasive Cancer Diagnostics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Non-Invasive Cancer Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Non-Invasive Cancer Diagnostics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Non-Invasive Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Non-Invasive Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Non-Invasive Cancer Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Non-Invasive Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Non-Invasive Cancer Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Non-Invasive Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Non-Invasive Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Non-Invasive Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Gen-Probe Inc Company Details
Table 31. Gen-Probe Inc Business Overview
Table 32. Gen-Probe Inc Non-Invasive Cancer Diagnostics Product
Table 33. Gen-Probe Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 34. Gen-Probe Inc Recent Development
Table 35. Digene Corporation Company Details
Table 36. Digene Corporation Business Overview
Table 37. Digene Corporation Non-Invasive Cancer Diagnostics Product
Table 38. Digene Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 39. Digene Corporation Recent Development
Table 40. Quest Diagnostics Inc Company Details
Table 41. Quest Diagnostics Inc Business Overview
Table 42. Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product
Table 43. Quest Diagnostics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 44. Quest Diagnostics Inc Recent Development
Table 45. Cancer, Genetics Inc Company Details
Table 46. Cancer, Genetics Inc Business Overview
Table 47. Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Product
Table 48. Cancer, Genetics Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 49. Cancer, Genetics Inc Recent Development
Table 50. BIOVIEW Inc Company Details
Table 51. BIOVIEW Inc Business Overview
Table 52. BIOVIEW Inc Non-Invasive Cancer Diagnostics Product
Table 53. BIOVIEW Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 54. BIOVIEW Inc Recent Development
Table 55. AVIVA Biosciences Corporation Company Details
Table 56. AVIVA Biosciences Corporation Business Overview
Table 57. AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product
Table 58. AVIVA Biosciences Corporation Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 59. AVIVA Biosciences Corporation Recent Development
Table 60. Laboratory Corporation of America Holdings (LabCorp) Company Details
Table 61. Laboratory Corporation of America Holdings (LabCorp) Business Overview
Table 62. Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product
Table 63. Laboratory Corporation of America Holdings (LabCorp) Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 64. Laboratory Corporation of America Holdings (LabCorp) Recent Development
Table 65. A&G Pharmaceutical Company Details
Table 66. A&G Pharmaceutical Business Overview
Table 67. A&G Pharmaceutical Non-Invasive Cancer Diagnostics Product
Table 68. A&G Pharmaceutical Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 69. A&G Pharmaceutical Recent Development
Table 70. Affymetrix Inc Company Details
Table 71. Affymetrix Inc Business Overview
Table 72. Affymetrix Inc Non-Invasive Cancer Diagnostics Product
Table 73. Affymetrix Inc Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 74. Affymetrix Inc Recent Development
Table 75. Precision Therapeutics Company Details
Table 76. Precision Therapeutics Business Overview
Table 77. Precision Therapeutics Non-Invasive Cancer Diagnostics Product
Table 78. Precision Therapeutics Revenue in Non-Invasive Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 79. Precision Therapeutics Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Invasive Cancer Diagnostics Product Picture
Figure 2. Global Non-Invasive Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Non-Invasive Cancer Diagnostics Market Size 2017-2028 (US$ Million)
Figure 4. United States Non-Invasive Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Non-Invasive Cancer Diagnostics Market Size 2017-2028 (US$ Million)
Figure 6. United States Non-Invasive Cancer Diagnostics Market Share in Global 2017-2028
Figure 7. Non-Invasive Cancer Diagnostics Report Years Considered
Figure 8. Product Picture of CTCs
Figure 9. Product Picture of CTNAS
Figure 10. Product Picture of Exosomes
Figure 11. Global Non-Invasive Cancer Diagnostics Market Share by Type in 2022 & 2028
Figure 12. Global Non-Invasive Cancer Diagnostics Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Non-Invasive Cancer Diagnostics Market Share by Type (2017-2028)
Figure 14. United States Non-Invasive Cancer Diagnostics Market Share by Type in 2022 & 2028
Figure 15. United States Non-Invasive Cancer Diagnostics Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Non-Invasive Cancer Diagnostics Market Share by Type (2017-2028)
Figure 17. Product Picture of Blood
Figure 18. Product Picture of Urine
Figure 19. Product Picture of Saliva
Figure 20. Global Non-Invasive Cancer Diagnostics Market Share by Application in 2022 & 2028
Figure 21. Global Non-Invasive Cancer Diagnostics Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Non-Invasive Cancer Diagnostics Market Share by Application (2017-2028)
Figure 23. United States Non-Invasive Cancer Diagnostics Market Share by Application in 2022 & 2028
Figure 24. United States Non-Invasive Cancer Diagnostics Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Non-Invasive Cancer Diagnostics Market Share by Application (2017-2028)
Figure 26. North America Non-Invasive Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Non-Invasive Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Non-Invasive Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Non-Invasive Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Non-Invasive Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. UAE Non-Invasive Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Gen-Probe Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 55. Digene Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 56. Quest Diagnostics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 57. Cancer, Genetics Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 58. BIOVIEW Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 59. AVIVA Biosciences Corporation Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 60. Laboratory Corporation of America Holdings (LabCorp) Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 61. A&G Pharmaceutical Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 62. Affymetrix Inc Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 63. Precision Therapeutics Revenue Growth Rate in Non-Invasive Cancer Diagnostics Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount